← All organizations
Highest phase reached
Phase 3
Timeline
1980s
- Jan 1, 1988
Pierrel Research— Founded
2000s
- Jun 1, 2005
PharmaPart— Acquired
2010s
- Feb 26, 2010
epinephrine— Marketing Organization
- Feb 26, 2010
epinephrine— NDA Secondary Org
Drugs by trial phase (16 distinct, 13 trials)
Phase 3 (8 own, 1 via acquisition)
Phase 2 (4 own, 2 via acquisition)
Phase 1 (1 own, 0 via acquisition)
Indications
Marketed drugs (2)
Subsidiaries (1 direct, 1 total across the full acquisition tree)
Recent trials (11)
- NCT02349906CollaboratorPhase 2Apr 1, 2015
- NCT01578239CollaboratorPhase 3Sep 1, 2012
- NCT01834742CollaboratorPhase 1Apr 1, 2011
- NCT01834742Overall official - principal investigatorPhase 1Apr 1, 2011
- NCT01251822Overall official - principal investigatorPhase 3Nov 1, 2010
- NCT01185223Lead sponsorPhase 3Sep 1, 2010
- NCT01168336Overall official - principal investigatorPhase 1Jul 1, 2010
- NCT01144429CollaboratorPhase 2Jun 1, 2010
- NCT01131624CollaboratorPhase 3May 1, 2010
- NCT01060748CollaboratorPhase 2Mar 1, 2010
- NCT00901654CollaboratorPhase 1Jun 1, 2009
Details
- Founded
- Sesto San Giovanni, IT Jan 1, 1988
- Last known activity
- Apr 1, 2015